Montelukast Sodium Chewable
制剂 FDF · — · 4mg; 5mg
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Montelukast Sodium Chewable
- Dosage Form
- —
- Strength
- 4mg; 5mg
- Therapy Area
- Respiratory
- Indication
- Asthma; Exercise-induced bronchospasm; Seasonal allergic rhinitis
- Current Status
- 官方 FDF 授权目录（UB194）
- GMP Certification
- US - FDA; CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —